Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tryp Therapeutics Inc (OP: TRYPF )

N/A UNCHANGED
Last Price Updated: 3:17 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tryp Therapeutics Inc

< Previous 1 2 3 4 5 Next >
Tryp Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference
San Diego, California--(Newsfile Corp. - September 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Contents 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE: 
Via Benzinga
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
San Diego, California--(Newsfile Corp. - August 24, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a... 
Via Newsfile
Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor
San Diego, California--(Newsfile Corp. - August 18, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a... 
Via Newsfile
Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations
San Diego, California--(Newsfile Corp. - August 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Tryp Therapeutics to Present at Canaccord Genuity Annual Growth Conference
San Diego, California--(Newsfile Corp. - August 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Tryp Therapeutics Announces Q3 2021 Financial Results
San Diego, California--(Newsfile Corp. - July 28, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a... 
Via Newsfile
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor
San Diego, California--(Newsfile Corp. - July 26, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Psyched: Cybin And Field Trip Head To Wall Street, AOC Pushes For Federal Psychedelics Research, Off-Label Ketamine Covered By Insurance In Canada
Cybin Inc. (NEO: CYBN) (OTCQB: 
Via Benzinga
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
San Diego, California--(Newsfile Corp. - July 21, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Exposures Product Safety
Tryp Therapeutics to Host Q3 Investor Day on July 29, 2021
San Diego, California--(Newsfile Corp. - July 15, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline
Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of&n... 
Via Benzinga
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations
San Diego, California--(Newsfile Corp. - July 7, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB:TRYPF) ("Tryp"), a pharmaceutical company focused... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Tryp Therapeutics to Present at the Psych Investor Summit
San Diego, California--(Newsfile Corp. - June 24, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical... 
Via Newsfile
Tryp Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
San Diego, California--(Newsfile Corp. - June 8, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical... 
Via Newsfile
Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference
San Diego, California--(Newsfile Corp. - June 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical... 
Via Newsfile
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
San Diego, California--(Newsfile Corp. - May 25, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical... 
Via Newsfile
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Via FinancialNewsMedia
Exposures Product Safety
Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support
San Diego, California--(Newsfile Corp. - May 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical... 
Via Newsfile
Exposures Product Safety
Tryp Therapeutics Partners with Fluence for Psychotherapy Design
San Diego, California--(Newsfile Corp. - May 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp") a... 
Via Newsfile
Exposures Product Safety
Tryp Therapeutics Announces Q2 2021 Financial Results
San Diego, California--(Newsfile Corp. - April 29, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), today announced... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
A Growing Market For Rare Disease Treatments Opens Up New Opportunities
Via FinancialNewsMedia
Tryp Therapeutics Reports on Key Milestones for 2021
San Diego, California--(Newsfile Corp. - April 20, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"),... 
Via Newsfile
Topics Initial Public Offering Intellectual Property
Exposures Intellectual Property Securities Market
Tryp Therapeutics to Host Investor Day on April 22
San Diego, California--(Newsfile Corp. - April 15, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"),... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.